HSBC Holdings
ARRY

HSBC Holdings’s Array Biopharma Inc ARRY Stock Holding History

HSBC Holdings’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,205
Closed -$371K – 2939
2019
Q1 		$371K Buy
+15,205
New +$317K ﹤0.01% 2244
2018
Q2 		– Sell
-144,583
Closed -$2.36M – 2769
2018
Q1 		$2.36M Buy
+144,583
New +$2.32M ﹤0.01% 1370
2017
Q1 		– Sell
-28,829
Closed -$253K – 2774
2016
Q4 		$253K Buy
+28,829
New +$212K ﹤0.01% 2367

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HSBC Holdings's ARRY Position: Q2 2019 in Review

HSBC Holdings sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 15,205 shares — an estimated $371K sold.

HSBC Holdings first reported a position in ARRY in Q4 2016 and held it in 3 quarters. The position peaked at $2.36M in Q1 2018. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • HSBC Holdings reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • HSBC Holdings sold 15,205 Array Biopharma Inc shares in Q2 2019, an estimated $371K.
  • HSBC Holdings first reported a position in Array Biopharma Inc in Q4 2016 and held it in 3 quarters.
  • HSBC Holdings's Array Biopharma Inc position peaked at $2.36M in Q1 2018.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on HSBC Holdings's 13F filing for Q2 2019, filed 13 Aug 2019.